Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennie Vagher

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
American Journal of Medical Genetics. Part A|February 23, 2023
Severe congenital neutropenia, SRP54 pathogenicity, and a framework for surveillanceElaine M Fan, Jennie Vagher, Jessica A Meznarich, et al.
Clinical Genetics|May 31, 2026
A Proposed Clinical Diagnostic Framework for Short Telomere SyndromeAndrew Courtwright, Richard A King, Jennie Vagher, et al.
Leukemia|October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomePeng Li, Thomas White, Wei Xie, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Blood|June 7, 2022
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasmsPeng Li, Sara Brown, Margaret Williams, et al.
Blood Advances|March 3, 2025
Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencingTing Wen, Steven E Boyden, Caleb M Hocutt, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Familial Cancer|August 11, 2025
Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatmentMarcelo M Sleiman, Muriel R Statman, Mary Rose Yockel, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
American Journal of Medical Genetics. Part A|February 23, 2023
Severe congenital neutropenia, SRP54 pathogenicity, and a framework for surveillanceElaine M Fan, Jennie Vagher, Jessica A Meznarich, et al.
Clinical Genetics|May 31, 2026
A Proposed Clinical Diagnostic Framework for Short Telomere SyndromeAndrew Courtwright, Richard A King, Jennie Vagher, et al.
Leukemia|October 21, 2021
AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcomePeng Li, Thomas White, Wei Xie, et al.
JCO Precision Oncology|June 20, 2025
Hematologic Malignancy Frequency, Phenotypes, and Outcomes in Li-Fraumeni SyndromeJennie Vagher, Anna Zakas, Lauren Donovan, et al.
Blood|June 7, 2022
The genetic landscape of germline DDX41 variants predisposing to myeloid neoplasmsPeng Li, Sara Brown, Margaret Williams, et al.
Blood Advances|March 3, 2025
Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencingTing Wen, Steven E Boyden, Caleb M Hocutt, et al.
Molecular Cancer Research : MCR|May 18, 2026
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Variation at the R181 residue of p53 confers loss of p53 DNA binding cooperativity with the retention of mitochondrial-associated apoptosisRenyta Moses, Alexandra Indeglia, Alison S Levine, et al.
Familial Cancer|August 11, 2025
Parental perspectives on the use of tumor molecular profiling and germline genetic testing during their children's cancer treatmentMarcelo M Sleiman, Muriel R Statman, Mary Rose Yockel, et al.
Pageof 3